CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in IBRX — ImmunityBio, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in IBRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$25,289,754
+$6,283,947 QoQ
Shares Held
2,888,607
+16.6% QoQ
Ownership
0.273%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 403 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IBRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. IBRX ranks #59 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in IBRX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,289,754 | 2,888,607 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $19,005,807 | 2,477,941 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,953,298 | 2,501,666 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $5,656,671 | 2,299,460 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $4,687,494 | 1,775,566 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $3,919,269 | 1,302,083 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $3,268,282 | 1,276,673 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $4,709,449 | 1,265,981 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $7,813,517 | 1,236,316 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $6,289,408 | 1,171,212 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $5,737,483 | 1,142,925 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,774,388 | 1,049,934 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $2,720,360 | 978,547 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,302,455 | 715,635 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $3,668,241 | 723,519 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,539,723 | 712,218 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,764,284 | 474,270 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,766,060 | 493,059 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,896,432 | 476,387 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $4,462,916 | 458,205 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $7,023,746 | 491,859 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $6,106,592 | 257,228 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 NK | — | 253,448 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 NK | — | 255,225 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 NK | — | 206,003 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 NK | — | 168,055 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||